Med Aditus International had spent 15 years building donor trust as a nonprofit fighting medication injustice in Africa. But when they launched pharmaceutical manufacturing in Kenya, the identical naming structure—MAI, MAP, MAK—created a crisis. Donors questioned whether funds were being diverted. Partners couldn’t figure out which entity to work with. Board members worried the for-profit ventures would taint their nonprofit reputation.

We researched eight dual-entity organizations and found the successful ones used subtle connecting elements—not identical names. Medicine 360 and FHI 360 showed us the path: maintain a thread between entities while creating clear visual separation. For Med Aditus, this meant keeping their name recognition but giving each entity its own distinct identity that wouldn’t trigger donor concerns about conflicts of interest.
The color palette and messaging do heavy lifting in the brand differentiation. Navy brings pharmaceutical credibility—the color of trust in healthcare. Teal adds the innovative edge that sets them apart from traditional manufacturers. Together, they create visual separation from the nonprofit’s palette while maintaining enough harmony to signal shared values. The new logo shares DNA with the nonprofit but stands distinctly apart—familiar elements for internal stakeholders who cherished the Med Aditus legacy, while geometric forms speak directly to regulatory bodies expecting modern pharmaceutical standards.

We developed a complete brand identity for Med Aditus Pharmaceuticals and built a WordPress site that showcases manufacturing capabilities, certifications, and expansion plans across Africa. Every page reinforces that this is a legitimate pharmaceutical company, not a nonprofit venture. The site architecture scales for future African markets without diluting brand equity. We created clear messaging frameworks that help them present to different audiences—pharmaceutical partners, regulatory bodies, and potential investors—without confusion about which entity does what.
